Advanced prostatic carcinoma--which hormone therapy when?
Studer, U.E.
Der Urologe. Ausg. a 34(5): 361-366
1995
ISSN/ISBN: 0340-2592 PMID: 7483149 Document Number: 448775
Document emailed within 1 workday
Related Documents
Klosterhalfen, H. 1977: Hormone therapy of prostatic carcinoma Deutsche Medizinische Wochenschrift 102(25): 947Ebert, T.; Bendhack, M.L. 1997: Prostatic carcinoma--diagnosis, hormone therapy, radio- and chemotherapy Der Urologe. Ausg. a 36(6): 570-577
Strnad, V.; Riepl, M.; Kühn, R.; Sauer, R. 1996: Radiochemotherapy and simultaneous hormonal therapy of locally advanced prostatic carcinoma Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 172(4): 225-228
La Vecchia, C.; Franceschi, S.; Gritti, P.; Valente, I. 1980: Hormone therapy in advanced forms of carcinoma of the endometrium: analysis and prospects Annali di Ostetricia Ginecologia Medicina Perinatale 101(3): 181-186
Fazio, M.; Cavallero, P.; Rattalino, G.; Sartoris, S.; Vergnano, F. 1976: Combination drug-hormone therapy of the advanced stages of breast carcinoma Minerva Ginecologica 28(7-8): 623-629
Bertelli, A. 1990: Introduction: recent progress in therapy of prostatic carcinoma and other hormone dependent pathology with the use of agonistic analogs of LHRH Drugs under Experimental and Clinical Research 16(Suppl): 1-2
Kumamoto, Y.; Tsukamoto, T.; Umehara, T.; Harada, M.; Shimazaki, J.; Fuse, H.; Oshima, H.; Takeuchi, H.; Yoshida, O.; Okada, K. 1990: Clinical studies on endocrine therapy of prostatic carcinoma (3): Histopathological features of prostatic carcinoma and its prognosis Hinyokika Kiyo. Acta Urologica Japonica 36(3): 295-305
Petru, E.; Beck, K.; Schünemann, H.; Schmähl, D. 1991: The significance of hormone receptor content in primary tumors for cytostatic therapy of advanced breast carcinoma Wiener Medizinische Wochenschrift 141(7): 133-135
Gez, E.; Ben-Yosef, R.; Libson, E.; Biran, S. 1987: The use of agonist analogues of luteinizing hormone--releasing hormone in the treatment of prostatic carcinoma Harefuah 112(5): 239-241
Strohmenger, P. 1980: Prostatic adenoma--prostatic carcinoma. Questions from general practice. II. Therapy Zfa. Zeitschrift für Allgemeinmedizin 56(28): 1793-1797
Matzkin, H.; Greenstein, A.; Kaver, I.; Braf, Z. 1989: Use of gonadotropin-releasing hormone analogue in advanced prostatic cancer: 3 years clinical experience Israel Journal of Medical Sciences 25(7): 388-392
Okumura, S.; Hasegawa, J.; Ohhara, M.; Kawamura, N.; Abe, H.; Yui, Y.; Kanamori, S.; Yoshida, K.; Nishimura, T.; Tomita, M. 1984: Treatment of advanced prostatic carcinoma with cis-diamminedichloroplatinum Hinyokika Kiyo. Acta Urologica Japonica 30(12): 1801-1807
Lohse, R.; Schubert, J. 1972: Treatment of advanced metastasizing prostatic carcinoma Das Deutsche Gesundheitswesen 27(26): 1238-1241
Rafla, S.; Johnson, R. 1974: The treatment of advanced prostatic carcinoma with medroxyprogesterone Current Therapeutic Research 16(4): 261-267
Vachalovský, V.; Vomácka, V. 1988: Orimeten in the treatment of advanced prostatic carcinoma Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 67(10): 666-670
Kuban, D.A.; Schellhammer, P.F.; el-Mahdi, A.M. 1991: Hemibody irradiation in advanced prostatic carcinoma Urologic Clinics of North America 18(1): 131-137
Korczak, D.; Golomb, J.; Siegel, Y.; Lindner, A. 1988: Treatment of advanced prostatic carcinoma with LHRH analogue Harefuah 115(5-6): 109-111
Tsukamoto, T.; Fukui, I.; Kihara, K.; Goto, S.; Kitahara, S.; Kobayashi, T.; Kojima, S.; Oshima, H. 1996: Combined hormone-chemotherapy for stage D2 prostatic cancer: starting time of chemotherapy in relation to hormone therapy Hinyokika Kiyo. Acta Urologica Japonica 42(5): 351-356
Svábenský, M. 1986: Ketoconazole--new possibilities of treatment in advanced stages of prostatic carcinoma Casopis Lekaru Ceskych 125(48): 1488-1489
Smith, P.H.; Akdas, A.; Mason, M.K.; Richards, B.; Robinson, M.R.; de Pauw, M.; Sylvester, R. 1980: Hormone therapy in prostatic cancer Acta Urologica Belgica 48(1): 98-105